Effectiveness of religious spiritual integrated therapy on the reduction of death distress in ?outpatients with generalized anxiety disorder
Phase 1
Recruiting
- Conditions
- Generalized anxiety disorder.F41.1
- Registration Number
- IRCT20180310039024N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Outpatients
Generalized Anxiety Disorder's patients
Exclusion Criteria
Chronic physical illness
Primary diagnosis of other anxiety disorders
Primary diagnosis of Major depression Disorder
Psychotic disorder
Drug dependence disorders
No individually/group psychological treatment or training
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death distress. Timepoint: Before of therapy, 2 weeks after of therapy, and 2 months after of therapy. Method of measurement: Death Anxiety Scale; Death Obsession Scale;, Death Depression Scale Scale.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie death distress reduction in generalized anxiety disorder through religious spiritual integrated therapy?
How does religious spiritual integrated therapy compare to SSRIs in managing death distress for F41.1 outpatients?
Are there specific biomarkers associated with response to religious spiritual integrated therapy in generalized anxiety disorder?
What adverse events are reported in phase I trials of religious spiritual integrated therapy for anxiety disorders?
What combination approaches or alternative therapies show efficacy in reducing death distress for generalized anxiety disorder patients?